Stryker Corporation
Location
Michigan
Founded
1941-02-28
Website
Risk Signals
3741 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Orthopedic, Prosthetic, and Surgical Appliances and Supplies), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Stryker Corporation
Live alerts from global media, monitored by Business Radar
2025-05-05 (investing.com)
UBS raises its share price target to $421, previously $405 Provider Investing.com
Investing.com — UBS analyst Danielle Antalffy raised the target price of Stryker stock to $421.00 from its previous $405.00, while maintaining a "neutral" rating on the stock. The $143.66 billion medical technology giant is currently trading close to its 52-week high of $406.19. According to InvestingPro analysis, the stock appears to be overvalued at the current level, with a price-to-earnings ratio of 50.13. The adjustment comes after Stryker's recent performance, with sales and earnings per share (EPS) exceeding expectations. In addition, the company's guidance on organic sales growth in 2025 also exceeded market consensus, and is now expected to grow 8.5% to 9.5% year-on-year, higher than the 8% to 9% forecast earlier.
Read more
2025-03-26 (investorshangout.com)
Exciting Updates for Stryker's Upcoming Shareholders Meeting - Investors Hangout
Discover key details of Stryker's Annual Meeting of Shareholders and their commitment to advancing healthcare technologies globally.
Read more
2025-03-26 (nasdaq.com)
Stryker Options Trading: A Deep Dive into Market Sentiment |
Investors with significant funds have taken a bearish position in Stryker (NYSE:SYK), a development that retail traders should be aware of.This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga. ...
Read more
2025-02-21 (biopharmadive.com)
Device industry scrambles amid concern FDA layoffs will cause delays |
Layoffs at the FDA's device center could add "months, if not years" to the time it takes to bring products to market, an attorney said.
Read more
(law360.com)
Fed. Circ. Wary Of Zimmer Call To Cut Stryker Patent Award
A panel of Federal Circuit judges on Monday questioned whether they should reconsider the $248 million in damages a lower court had ordered Zimmer Inc. to pay for infringing Stryker Corp.'s surgical tool patents.
Read more